Atossa Genetics Inc. (ATOS) announced Wednesday morning that it has entered into a contractual agreement with FedMed Inc., which will give FedMed's participating providers and its clients' members greater access to Atossa's tests.
Atossa Genetics has been climbing sharply since the open of trade Wednesday and is now up 2.10 at $8.70 on the highest volume in 3 months. The stock has risen above a one-month range and has set a new high.
For comments and feedback contact: editorial@rttnews.com
Business News
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.